4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008758
10% owner bought 350,000 shares at $20.00 ($7,000,000)
- 10% owner sold 226 shares at $20.00 ($4,520)
- 10% owner acquired 64,319 shares (option exercise)
- 10% owner acquired 3,414,343 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion | +944,056 | 958,341 | I: show line 1 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion | +472,296 | 1,430,637 | I: show line 2 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Option exercise | +17,711 | $0.07 | $1,240 | 1,448,348 | I: show line 3 in the form |
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Sale | −62 | $20.00 | $1,240 | 1,448,286 | I: show line 4 in the form |
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion | +1,092,080 | 1,117,184 | I: show line 5 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion | +317,922 | 1,435,106 | I: show line 6 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion | +345,568 | 1,780,674 | I: show line 7 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Option exercise | +40,953 | $0.07 | $2,867 | 1,821,627 | I: show line 8 in the form |
| Open-market purchases · 350,000 sh · avg $20.00 · $7,000,000 | |||||||
| Open-market sales · 226 sh · avg $20.00 · $4,520 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series A-1 Preferred Stock | −944,056 | 0 | I: show line 18 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series B Preferred Stock | −472,296 | 0 | I: show line 19 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Option exercise · Warrant (Right to Buy) | −17,711 | 0 | I: show line 20 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series B Preferred Stock | −1,092,080 | 0 | I: show line 21 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series C-1 Preferred Stock | −317,922 | 0 | I: show line 22 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series C-2 Preferred Stock | −345,568 | 0 | I: show line 23 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Option exercise · Warrant (Right to Buy) | −40,953 | 0 | I: show line 24 in the form | ||
| Vivo Capital VIII, LLC 10% owner | 2021-02-09 | Conversion · Series B Preferred Stock | −150,802 | 0 | I: show line 25 in the form |
Loading xslF345X03/doc4.xml…